Filter by: patients
What is Mepron?

Mepron® is the brand name for atovaquone, an antiprotozoal used for treatment of mild-to-moderate Pneumocystis jirovecii pneumonia (PCP) in patients who are intolerant to co-trimoxazole and for prophylaxis of PCP in patients who are intolerant to co-trimoxazole.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Other 6 1 Efficacy_cant_tell
Lyme Disease 3 0
Anti-infective 2 0
Prevent infection 2 1 Efficacy_cant_tell
Pneumonia symptoms 1 0
Pneumocystis Carinii Pneumonia (PCP) 1 0

See all 8 patients currently taking Mepron

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
1
None
2

Reported Dosages

  750 mg/5 mL weekly 750 mg/5 mL daily 2 x 750 mg/5 mL daily
  1 Number of Patients: 1 2 Number of Patients: 2 5 Number of Patients: 5  

Reported Stop Reasons

Why Patients Stopped Taking Mepron (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 5   Course of treatment ended: 50%
Doctor's advice 4   Doctor's advice: 40%
Did not seem to work 2   Did not seem to work: 20%
Side effects too severe 1   Side effects too severe: 10%

See all 10 patients who’ve stopped taking Mepron

Currently Taking Mepron

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Mepron

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Mepron

Always
3 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Mepron

Very
0 0%
Somewhat
0 0%
A little
1 33%
Not at all
2 67%

Cost

Paid out of pocket

Cost of Mepron

$200+
0 0%
$100-199
0 0%
$50-99
1 33%
$25-49
1 33%
< $25
1 33%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 25, 2012.